0001209191-11-051416.txt : 20111011
0001209191-11-051416.hdr.sgml : 20111010
20111011160940
ACCESSION NUMBER: 0001209191-11-051416
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110930
FILED AS OF DATE: 20111011
DATE AS OF CHANGE: 20111011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Friedman Mark Louis
CENTRAL INDEX KEY: 0001531023
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-16159
FILM NUMBER: 111135648
MAIL ADDRESS:
STREET 1: AXOGEN, INC
STREET 2: 13859 PROGRESS BLVD SUITE 100
CITY: ALACHUA
STATE: FL
ZIP: 32615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AxoGen, Inc.
CENTRAL INDEX KEY: 0000805928
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411301878
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1407 S. KINGS HIGHWAY
CITY: TEXARKANA
STATE: TX
ZIP: 75501
BUSINESS PHONE: (903) 280-8454
MAIL ADDRESS:
STREET 1: 1407 S. KINGS HIGHWAY
CITY: TEXARKANA
STATE: TX
ZIP: 75501
FORMER COMPANY:
FORMER CONFORMED NAME: LECTEC CORP /MN/
DATE OF NAME CHANGE: 19920703
3
1
c23219_3x0.xml
MAIN DOCUMENT DESCRIPTION
X0204
3
2011-09-30
0
0000805928
AxoGen, Inc.
LECT
0001531023
Friedman Mark Louis
C/O AXOGEN, INC.
13859 PROGRESS BOULEVARD, SUITE 100
ALACHUA
FL
32615
0
1
0
0
See Remarks
Stock Option
0.25
2006-10-17
2016-10-17
Common Stock
3727
D
Stock Option
0.25
2007-04-27
2017-04-27
Common Stock
1028
D
Stock Option
0.25
2007-12-06
2017-12-06
Common Stock
601
D
Stock Option
0.25
2008-11-18
2018-11-18
Common Stock
309
D
Stock Option
1.00
2011-06-20
2021-06-20
Common Stock
16829
D
Pursuant to an Agreement and Plan of Merger, dated as of May 31, 2011, by and among LecTec Corporation ("LecTec"), Nerve Merger Sub Corp., a subsidiary of LecTec ("Merger Sub"), and AxoGen Corporation ("AC"), which the parties amended on June 30, 2011 and August 9, 2011 (as amended, the "Merger Agreement"), Merger Sub merged with and into AC, with AC continuing after the merger as the surviving corporation and a wholly owned subsidiary of LecTec (the "Merger"). The Merger was completed on September 30, 2011, and LecTec was renamed AxoGen, Inc. ("AxoGen"). In connection with the Merger, each option to purchase shares of AC common stock was converted to an option to purchase 0.03727336 of a share of AxoGen common stock.
100% of the options have vested.
526 options have vested, and 75 options are unvested.
193 options have vested, and 116 options are unvested.
None of the options have vested.
These options vest semi-annually over four years from the date of grant.
Vice President of Regulatory Affairs and Quality Assurance of AxoGen Corporation, a wholly owned subsidiary of Autogen, Inc.
/s/ Mark Friedman
2011-10-11